BR112014005362A2 - vacinas de tumor com nanopartículas - Google Patents
vacinas de tumor com nanopartículasInfo
- Publication number
- BR112014005362A2 BR112014005362A2 BR112014005362A BR112014005362A BR112014005362A2 BR 112014005362 A2 BR112014005362 A2 BR 112014005362A2 BR 112014005362 A BR112014005362 A BR 112014005362A BR 112014005362 A BR112014005362 A BR 112014005362A BR 112014005362 A2 BR112014005362 A2 BR 112014005362A2
- Authority
- BR
- Brazil
- Prior art keywords
- tumor vaccines
- nanoparticle tumor
- nanoparticle
- vaccines
- tumor
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 239000002105 nanoparticle Substances 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6923—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
- A61K47/6929—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/80—Vaccine for a specifically defined cancer
- A61K2039/86—Lung
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161531730P | 2011-09-07 | 2011-09-07 | |
| PCT/EP2012/067579 WO2013034741A1 (en) | 2011-09-07 | 2012-09-07 | Nanoparticle tumour vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112014005362A2 true BR112014005362A2 (pt) | 2017-06-13 |
Family
ID=46970246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014005362A BR112014005362A2 (pt) | 2011-09-07 | 2012-09-07 | vacinas de tumor com nanopartículas |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20140248360A1 (pt) |
| EP (1) | EP2753361A1 (pt) |
| JP (1) | JP2014531427A (pt) |
| KR (1) | KR20140084020A (pt) |
| CN (1) | CN103957943A (pt) |
| AU (1) | AU2012306258A1 (pt) |
| BR (1) | BR112014005362A2 (pt) |
| CA (1) | CA2847907A1 (pt) |
| EA (1) | EA201490520A1 (pt) |
| MX (1) | MX2014002764A (pt) |
| WO (1) | WO2013034741A1 (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX345883B (es) * | 2011-09-07 | 2017-02-22 | Midatech Ltd | Composiciones de peptidos en nanoparticulas. |
| WO2014046807A1 (en) * | 2012-09-20 | 2014-03-27 | Board Of Regents, The University Of Texas System | Hydrophobic shielding for enhanced nanoparticle stability |
| US20150064107A1 (en) * | 2013-09-04 | 2015-03-05 | King's College London | Imaging agent |
| EP2921179A1 (en) * | 2014-03-17 | 2015-09-23 | Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) | Micellar nanoparticles containing antitumoral glycosides |
| GB201507030D0 (en) | 2015-04-24 | 2015-06-10 | Immatics Biotechnologies Gmbh | Immunotherapy against lung cancers, in particular NSCLC |
| CN108588020B (zh) * | 2018-03-30 | 2021-09-14 | 中国科学院苏州纳米技术与纳米仿生研究所 | 一种含有硒元素的近红外ii区量子点的新应用 |
| EP3983003A1 (en) * | 2019-06-11 | 2022-04-20 | Pharmaexceed S.r.l. | Nanoparticles for use in the redirection against the tumour of a non-tumour-specific immune response, based on a pre-existing immunity |
| EP3909612A1 (en) | 2020-05-12 | 2021-11-17 | Life Science Inkubator Betriebs GmbH & Co. KG | Composition of nanoparticles |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0025414D0 (en) | 2000-10-16 | 2000-11-29 | Consejo Superior Investigacion | Nanoparticles |
| GB0313259D0 (en) | 2003-06-09 | 2003-07-16 | Consejo Superior Investigacion | Magnetic nanoparticles |
| ES2242528B1 (es) | 2004-03-25 | 2006-12-01 | Consejo Sup. Investig. Cientificas | Nanoparticulas magneticas de metales nobles. |
| JP5398982B2 (ja) | 2004-05-24 | 2014-01-29 | ミダテック リミテッド | Ｒｎａリガンドを含むナノ粒子 |
| EP1793863B1 (en) | 2004-10-01 | 2017-04-12 | Midatech Ltd. | Nanoparticles comprising antigens and adjuvants capable of stimulating t helper cells |
| CN101123990A (zh) * | 2004-10-01 | 2008-02-13 | Mida科技有限公司 | 包含抗原和佐剂的纳米颗粒，和免疫原性结构 |
| WO2007015105A2 (en) * | 2005-08-04 | 2007-02-08 | Thomas William Rademacher | Nanoparticles comprising antibacterial ligands |
| CA2652759C (en) | 2006-04-13 | 2014-07-08 | Midatech Limited | Nanoparticles for providing immune responses against infectious agents |
| EP2161279A1 (en) * | 2008-08-29 | 2010-03-10 | Centre National de la Recherche Scientifique | Synthetic peptides corresponding to overlapping neutralizing determinants in the CBD1 epitope induce broadly neutralizing antibodies |
| RU2600798C2 (ru) * | 2009-04-01 | 2016-10-27 | Юниверсити Оф Майами | Композиции вакцин и способы их применения |
| AU2010286940A1 (en) | 2009-08-26 | 2012-03-08 | Immunotope, Inc. | Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| EP2305310A1 (en) | 2009-09-25 | 2011-04-06 | Asociación Centro de Investigación Cooperativa en Biomateriales - CIC biomaGUNE | Gold -coated magnetic glyconanoparticles functionalised with proteins for use as diagnostic and therapeutic agents |
| TWI485245B (zh) * | 2010-01-25 | 2015-05-21 | Oncotherapy Science Inc | 經修飾之ｍｅｌｋ胜肽及含此胜肽之疫苗 |
| MX345883B (es) * | 2011-09-07 | 2017-02-22 | Midatech Ltd | Composiciones de peptidos en nanoparticulas. |
-
2012
- 2012-09-07 WO PCT/EP2012/067579 patent/WO2013034741A1/en active Application Filing
- 2012-09-07 JP JP2014529006A patent/JP2014531427A/ja active Pending
- 2012-09-07 KR KR1020147009101A patent/KR20140084020A/ko not_active Application Discontinuation
- 2012-09-07 AU AU2012306258A patent/AU2012306258A1/en not_active Abandoned
- 2012-09-07 EP EP12768753.1A patent/EP2753361A1/en not_active Withdrawn
- 2012-09-07 EA EA201490520A patent/EA201490520A1/ru unknown
- 2012-09-07 CA CA2847907A patent/CA2847907A1/en not_active Abandoned
- 2012-09-07 US US14/343,435 patent/US20140248360A1/en not_active Abandoned
- 2012-09-07 CN CN201280052020.2A patent/CN103957943A/zh active Pending
- 2012-09-07 MX MX2014002764A patent/MX2014002764A/es unknown
- 2012-09-07 BR BR112014005362A patent/BR112014005362A2/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP2753361A1 (en) | 2014-07-16 |
| JP2014531427A (ja) | 2014-11-27 |
| WO2013034741A1 (en) | 2013-03-14 |
| KR20140084020A (ko) | 2014-07-04 |
| AU2012306258A1 (en) | 2014-04-17 |
| MX2014002764A (es) | 2014-12-04 |
| CN103957943A (zh) | 2014-07-30 |
| EA201490520A1 (ru) | 2014-09-30 |
| US20140248360A1 (en) | 2014-09-04 |
| CA2847907A1 (en) | 2013-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR23C1020I2 (fr) | Conjugues pyrrolobenzodiazepine-anticorps | |
| SMT201600476B (it) | Tenofovir alafenammide emifumarato | |
| BR112014007603A2 (pt) | métodos de tratamento do câncer | |
| DK2906251T3 (da) | Pyrrolobenzodiazepin-anti-CD22-antistofkonjugater | |
| DK2920304T3 (da) | Oligonukleotidkonjugater | |
| BR112015008232A2 (pt) | conjugados pirrolbenzodiazepina-anticorpo | |
| DK2707030T3 (da) | Cancerbehandlinger | |
| BR112013032887A2 (pt) | cateter | |
| BR112014029111A2 (pt) | inalador | |
| BR112014012880A2 (pt) | tratamento imunogênico do câncer | |
| DK2841054T4 (da) | Injicerbart præparat | |
| DK2668967T3 (da) | Implantat | |
| DK2760886T3 (da) | Immunocytokin-kombinationsterapi | |
| BR112013033974A2 (pt) | terapia de combinação | |
| DK2834348T3 (da) | 3d in vitro bifasisk brusk-knogle-konstruktion | |
| SMT201600082B (it) | Vaccino pcsk9 | |
| FI20115876A0 (fi) | Yhdistelmähoito | |
| BR112014005362A2 (pt) | vacinas de tumor com nanopartículas | |
| DK3446714T3 (da) | Anti-nucleolinmiddel-konjugerede nanopartikler | |
| SG11201500396TA (en) | Tumor vaccination | |
| EP2876161A4 (en) | VACCINE | |
| FR2975090B1 (fr) | Nanoparticules autodispersantes | |
| CO6880064A2 (es) | Métodos terapéuticos | |
| DK3536334T3 (da) | Cancer stamcelle målrettede cancer vacciner | |
| FR2975564B1 (fr) | Charrue |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11N | Dismissal: publication cancelled [chapter 11.14 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08H | Application fees: decision cancelled [chapter 8.8 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Ipc: A61K 9/14 (2006.01), A61K 39/00 (2006.01), A61K 47 |
|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |